Author

Debora Mazzetti

Institutions: Brigham and Women's Hospital, Harvard University, University of Campania "Luigi Vanvitelli", Mass General Brigham

Observed institutions: Brigham and Women's Hospital, Harvard University, University of Campania "Luigi Vanvitelli", Mass General Brigham

ORCID: 0009-0008-1767-7815

Observed ORCID: 0009-0008-1767-7815

OpenAlex ID: A5092761845

Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms

2024 · Christopher Chang, Velina S. Chavarro, et al. · International Journal of Molecular Sciences · 51

Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas

2023 · Pierpaolo Peruzzi, Christine Dominas, et al. · Science Translational Medicine · 24

HNRNPH1 drives glioblastoma progression by regulating the splicing of cell cycle genes

2026 · Genaro R. Villa, Paolo Alimonti, et al. · Cell Death and Disease · 2

In vivo scAAV-based NeuroD1 gene therapy inhibiting glioblastoma growth

2026 · Debora Mazzetti, Pier Paolo Peruzzi, et al. · Molecular Therapy Oncology

Accessory microRNA byproducts expand RNA interference via microprocessor-mediated cleavage activation

2026 · Debora Mazzetti, Michal O. Nowicki, et al. · Science Advances

Works count: 5

Citation count: 77

H-index: 2

I10-index: 2